2020 Virtual ESMO Review
2020 ESMO Update on MBC: Is There OS Benefit to Alpelisib + Fulvestrant in PI3KCA-Mutated HR+ MBC? Does Sacituzumab Govitecan Improve PFS & OS Over Standard Chemotherapy in mTNBC?
By
2020 Virtual ESMO Review
FEATURING
Jennifer Crozier
By
2020 Virtual ESMO Review
FEATURING
Jennifer Crozier
Comments 0
Login to view comments.
Click here to Login
